NCT01794780View on ClinicalTrials.gov

A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

PHASE4CompletedINTERVENTIONAL
Enrollment

2,229

Participants

Timeline

Start Date

February 5, 2013

Primary Completion Date

May 25, 2015

Study Completion Date

May 25, 2015

Conditions
COPD
Interventions
DRUG

LABA based treatment: indacaterol

LABA based treatment: indacaterol

DRUG

LAMA based treatment: tiotropium

LAMA based treatment: tiotropium

DRUG

LABA/ICS based treatment: salmeterol/fluticasone

LABA/ICS based treatment: salmeterol/fluticasone

DRUG

LABA/ICS based treatment: budesonide/formoterol

LABA/ICS based treatment: budesonide/formoterol

DRUG

theophylline based treatment

theophylline based treatment

DRUG

Other treatment

"non-long-acting bronchodilators for COPD treatment, such treatments were classified as other treatments"

Trial Locations (2)

100730

Novartis Investigative Site, Beijing

Unknown

Novartis Investigative Site, Zhengzhou

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY